Introduction {#s1}
============

Diabetes mellitus (DM) is a metabolic disorder characterized by chronic hyperglycemia due to defects in insulin action and secretion ([@B1], [@B2]). In China, the prevalence of DM is about 9.7% in the population \>18 years of age and about 20% in the population over 60 years of age ([@B3]). DM-associated complications include nephropathy, neuropathy, retinopathy, cardiovascular diseases, and metabolic syndromes ([@B4]). In the male reproductive system, glucose homeostasis is important for spermatogenesis. There is growing evidence showing that DM can cause damage to the male reproductive system, including decreased testicular weight and sperm number and motility and increased abnormal sperm number ([@B5]). So far, the molecular mechanisms underlying DM-induced male reproductive dysfunction remain elusive.

*Lycium barbarum* has long been well-known as a traditional Chinese medicine that promotes health and longevity and is mainly cultivated in the Ningxia district of China ([@B6], [@B7]). Studies have shown that *Lycium barbarum* polysaccharides (LBP) possess multiple pharmacological functions including immunomodulatory, antioxidant, hypolipidemic, anti-tumor, and anti-aging functions ([@B8]--[@B12]). Recently, several lines of evidence have indicated the protective effects of LBP on the male reproductive damage induced by radiation ([@B13]), chemotherapeutic reagents ([@B14], [@B15]), nonylphenol ([@B16]), and corticosterone ([@B17]). In a diabetic animal model, LBP could attenuate diabetic testicular dysfunction *via* inhibition of the PI3K/Akt pathway-mediated abnormal autophagy in male mice ([@B18]). Shi et al. showed that LBP could exert protective effects on DM-induced spermatogenic dysfunction by increasing antioxidative enzyme activities and inhibiting cell death ([@B19]). In addition, LBP could exert functional recovery of male sexual dysfunction and fertility damage induced by DM in male mice by regulating the hypothalamus-pituitary-gonadal axis endocrine activity ([@B20]). However, detailed investigation into the molecular mechanisms underlying LBP-mediated protective effects on male reproductive dysfunction induced by DM is required.

Sirtuin 1 (SIRT1) belongs to the mammalian superfamily of sirtuins ([@B21]). SIRT1 has been identified to be upregulated under diabetic conditions, and it can regulate glucose metabolism *via* deacetylase activity on respective targets ([@B21]). In pancreatic β-cells, SIRT1 can promote the secretion of insulin and protect cells against oxidative stress and inflammation ([@B21]). Additionally, studies have found that SIRT1 was significantly decreased in infertile oligoasthenoteratozoospermic men with varicocele ([@B22], [@B23]). In animal studies, SIRT1 was reported to regulate acrosome biogenesis by modulating autophagic flux during spermiogenesis in mice ([@B24]). Recent findings revealed that ferulic acid protects male rats against radiation-induced testicular damage by increasing SIRT1 expression ([@B25]). Existing evidence indicates the importance of SIRT1 in the male reproductive system. Hypoxia-inducible factor 1-alpha (HIF-1α) is a hypoxia-activated transcription factor that confers protective effects in hypoxic conditions ([@B26]). Studies have shown the dysregulated expression of HIF-1α under diabetic conditions ([@B27]). Testis is a relatively hypoxic tissue, and HIF-1α regulates the primary transcriptional responses to hypoxic stress in normal and transformed cells, which play an adaptive role in conferring protection against cell death in the testes ([@B28]). Studies have also reported that SIRT1 deacetylates and stabilizes HIF-1α through direct interactions ([@B29]), implying that the SIRT1/HIF-1α axis may be an important mediator in protection against male reproductive dysfunction induced by DM.

In the present study, we aimed to determine the protective effects of LBP on spermatogenic dysfunction in streptozotocin (STZ)-induced diabetic rats using immunohistochemical analysis of proliferating cell nuclear antigen (PCNA) expression, cell apoptosis, sirtuin 1 (SIRT1), and hypoxia-inducible factor 1-alpha (HIF-1α) expression in the testes. The present study may further advance our understanding of molecular mechanisms of LBP-mediated protective effects on DM-induced male reproductive dysfunction.

Materials and Methods {#s2}
=====================

Preparation of LBP and Metformin
--------------------------------

LBP was prepared based on previous methods ([@B9]) and was purchased from Xi'an Xiaocaokeji Ltd. (Xi\', China). Metformin was purchased from Sigma-Aldrich (St. Louis, USA). LBP and metformin were dissolved in saline for oral administration.

Animals and Induction of Diabetes
---------------------------------

Male Sprague-Dawley rats (4--6 weeks old, body weight 170 ± 10 g) were purchased from the Animal Experimental Center of Daping Hospital, Third Military Medical University. All experimental procedures were approved by the Animal Ethics Committee of Zunyi Medical University. For the induction of diabetes, rats were fed a high-fat diet for 6 weeks and then intraperitoneally injected with 45 mg/kg STZ (dissolved in 0.1 M citrate buffer at pH 4.5). The fasting blood glucose levels were monitored for 3 consecutive days after STZ injection, and rats with fasting glucose levels ≥ 16.7 mM were considered diabetic.

Treatment Groups
----------------

Rats were randomly divided into four groups: the control group (control group, *n* = 6), DM + saline group (model group, *n* = 6), DM + metformin group (*n* = 6), and DM + LBP group (*n* = 6). For the control group, rats were fed a basal diet for 6 weeks and were then orally administered saline (1 mL/kg/d). For the DM + saline group, diabetic rats were orally administered saline (1 mL/kg/d). For the DM + metformin group, diabetic rats were orally administered metformin (100 mg/kg/d). For the DM + LBP group, diabetic rats were orally administered LBP (100 mg/kg/d). All the rats were fed with a basal diet during the drug treatments, and after a 6 week treatment, rats were sacrificed, and relevant tissues were collected for further analysis.

Measurement of Blood Glucose and Insulin Levels and Homeostatic Model Assessment of Insulin Resistance (HOMA-IR)
----------------------------------------------------------------------------------------------------------------

One day before the end of the experiments, animals were fasted overnight, and then blood glucose levels were detected using a Glucose Meter (Contournext, Parsippany, USA), while blood insulin levels were detected using a commercial insulin kit (Abcam, Cambridge, USA). HOMA-IR was calculated based on the following formula: (fasting blood glucose levels × fasting blood insulin levels)/22.5.

Assessment of Sperm Number and Motility
---------------------------------------

Sperm samples were collected from the testicular tissues and incubated in saline at 37°C. Sperm number and motility were evaluated using a computer-aided sperm analysis system (Sperm Class Analyzer, MICROPTIC, Barcelona, Spain).

Histopathological Examination
-----------------------------

The testicular tissues were dissected and fixed in 4% paraformaldehyde overnight at 4°C, embedded in paraffin, sectioned into 5-μm-thick slices, deparaffinized, and stained with hematoxylin and eosin. The morphology of the testes and the number of spermatogonia and spermatocytes were evaluated under a light microscope.

Immunohistochemical Analysis of Proliferating Cell Nuclear Antigen (PCNA), Sirtuin 1 (SIRT1), and Hypoxia-Inducible Factor 1-Alpha (HIF-1α) Expression
------------------------------------------------------------------------------------------------------------------------------------------------------

The 5-μm-thick deparaffinized slices were rehydrated using 100 to 75% ethanol. Antigen retrieval was performed by incubating the slices with sodium citrate buffer with an application of high voltage for 3 min. Then, the slices were incubated with 3% H~2~O~2~-methanol solution at room temperature for 10 min. The slices were blocked with 5% bovine serum albumin in 1% Triton X-100 phosphate buffered saline (PBS) at room temperature for 1 h, followed by incubation with PCNA, SIRT1, and HIF-1α primary antibodies at 4°C overnight. After washing the sections with PBS thrice for 5 min each, the slices were incubated with biotinylated anti-rabbit immunoglobulin G at room temperature for 1 h. The slices were then incubated with avidin-biotin-peroxidase complexes. The antigens were visualized after incubation with DAB solution. The number of PCNA-, SIRT1- and HIF-1α-positive cells were evaluated under a light microscope.

Terminal Deoxynucleotidyl Transferase-Mediated dUTP Nick-End Labeling (TUNEL) Assay
-----------------------------------------------------------------------------------

Apoptosis in testicular tissues was evaluated by TUNEL assay. The 5-μm-thick deparaffinized slices were rehydrated using 100 to 75% ethanol. The slices were incubated with 1% Triton X-100 at room temperature for 30 min and were then incubated with 3% H~2~O~2~-methanol solution at room temperature for 10 min. After that, proteinase K was added to the slices, and they were incubated for 15 min. The slices were incubated with TdT-enzyme at 37°C for 1 h and washed with PBS thrice for 5 min each. Then, 100 μL of digoxigenin (conjugated to horseradish peroxidase, POD) was placed on each section; 3, 3′-Diaminobenzidine (DAB) was used as a staining agent. Apoptotic cells were stained brown and analyzed by randomly counting TUNEL-positive cells.

Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR)
----------------------------------------------------------

Total RNA from testicular tissues was extracted using TRIzol reagent (Invitrogen, Carlsbad, USA). RNA was reverse transcribed into cDNA using the PrimeScript 1st strand cDNA Synthesis Kit (Takara Bio, Dalian, China). Real-time PCR was performed on an ABI7900 PCR system (Applied Biosystems, Foster City, USA) using SYBR® Green Real-Time PCR Master Mix (Takara Bio). GAPDH was used as an internal control for relevant mRNA expression. The relative expression of PCNA mRNA was calculated using the comparative Ct method. The primer sequences are shown in [Table 1](#T1){ref-type="table"}.

###### 

Primer sequences of target genes.

  **Gene**    **Sequences (5^**′**^-3^**′**^)**
  ----------- -----------------------------------
  PCNA        F: GCTCCATCCTGAAGAAGGT
              R: TGCACTAAGGAGACGTGAGA
  Bax         F: GAGACACCTGAGCTGACCTT
              R: TCCATGTTGTTGTCCAGTTC
  Bcl-2       F: AGTACCTGAACCGGCATCT
              R: TCTTCAGAGACAGCCAGGA
  Caspase-3   F: CCGGTTACTATTCCTGGAGA
              R: TAACACGAGTGAGGATGTGC
  SIRT1       F: GTGGCAGTAACAGTGACAGTG
              R: GTCAGCTCCAGATCCTCCAG
  GAPDH       F: CCTCAAGATTGTCAGCAATG
              R: CAGTCTTCTGAGTGGCAGTG

Statistical Analysis
--------------------

All data analyses were performed using GraphPad Prism (Version 6.0, GraphPad Software, La Jolla, USA). Data are presented as mean ± standard deviation. Significant differences among different treatment groups were analyzed using one-way ANOVA followed by Dunnett\'s *post-hoc* test. *P* \< 0.05 was considered statistically significant.

Results {#s3}
=======

Effects of Metformin and LBP Treatments on Body Weight, Blood Glucose, Insulin Levels, and Insulin-Resistant Index in Diabetic Rats
-----------------------------------------------------------------------------------------------------------------------------------

Initially, we observed that saline-treated diabetic rats had lower body weight than the controls and that metformin treatment increased body weight in diabetic rats when compared to saline-treated diabetic rats. However, LBP treatment failed to significantly increase body weight compared to saline-treated diabetic rats ([Table 2](#T2){ref-type="table"}). Before any treatment, diabetic rats had higher fasting glucose levels than the control group, but metformin and LBP treatments both reduced fasting glucose levels compared to saline-treated diabetic rats ([Table 2](#T2){ref-type="table"}). Saline-treated diabetic rats had higher fasting insulin levels than the controls, while metformin and LBP treatments further increased fasting insulin levels compared to saline-treated diabetic rats ([Table 2](#T2){ref-type="table"}). In addition, the increased insulin resistance index in diabetic rats was alleviated by treatment with metformin or LBP ([Table 2](#T2){ref-type="table"}).

###### 

Effects of metformin and LBP treatments on the body weight, blood glucose, insulin levels, and insulin-resistant index in diabetic rats.

  **Group**        **Body weight (g)**   **Fasting blood glucose (mM)**                                                      **Fasting insulin (μIU/mL)**                       **Insulin resistance index**                                                                                                         
  ---------------- --------------------- ----------------------------------------------------------------------------------- -------------------------------------------------- ------------------------------------------------- ---------------------------------------------------------------------------------- ------------------------------------------------
  Control          329.3 ± 6.732         389.7 ± 9.234                                                                       6.358 ± 0.4870                                     5.112 ± 0.2141                                    71.35 ± 12.48                                                                      21.87 ± 2.33
  DM + saline      321.8 ± 15.14         234.9 ± 21.18[^\*^](#TN1){ref-type="table-fn"}                                      21.48 ± 0.6938[^\*^](#TN1){ref-type="table-fn"}    28.53 ± 0.7424[^\*^](#TN1){ref-type="table-fn"}   99.88 ± 22.24[^\*^](#TN1){ref-type="table-fn"}                                     178.8 ± 48.62[^\*^](#TN1){ref-type="table-fn"}
  DM + Metformin   328.9 ± 8.412         348.7 ± 11.25[^\*^](#TN1){ref-type="table-fn"}[^\#^](#TN2){ref-type="table-fn"}     19.255 ± 0.4487[^\*^](#TN1){ref-type="table-fn"}   5.354 ± 0.2388[^\#^](#TN2){ref-type="table-fn"}   177.45 ± 41.28[^\*^](#TN1){ref-type="table-fn"}[^\#^](#TN2){ref-type="table-fn"}   41.56 ± 14.14[^\#^](#TN2){ref-type="table-fn"}
  DM + LBP         322.0 ± 7.225         294.2 ± 17.34[^\*^](#TN1){ref-type="table-fn"}[^*\$*^](#TN3){ref-type="table-fn"}   23.77 ± 1.4520[^\*^](#TN1){ref-type="table-fn"}    7.600 ± 1.6000[^\#^](#TN2){ref-type="table-fn"}   143.20 ± 26.28[^\*^](#TN1){ref-type="table-fn"}[^\#^](#TN2){ref-type="table-fn"}   50.23 ± 19.06[^\#^](#TN2){ref-type="table-fn"}

P \< 0.05 vs. Control;

P \< 0.05 vs. DM + saline group;

*P \< 0.05 vs. DM + Metformin group*.

Effects of Metformin and LBP on Testis and Epididymis Weight, Sperm Number, and Motility
----------------------------------------------------------------------------------------

As shown in [Table 3](#T3){ref-type="table"}, the saline-treated diabetic rats had lower testis and epididymis weight and also reduced sperm number and motility compared to controls ([Table 3](#T3){ref-type="table"}). Both metformin and LBP treatments significantly increased the testis and epididymis weight and also increased sperm number and motility compared to saline-treated diabetic rats ([Table 3](#T3){ref-type="table"}).

###### 

Effects of metformin and LBP on testis and epididymis weight and sperm number and motility.

  **Group**        **Testis weight (g)**                            **Epididymis weight (g)**                          **Sperm number (× 10^**6**^)**                   **Sperm motility (%)**
  ---------------- ------------------------------------------------ -------------------------------------------------- ------------------------------------------------ ------------------------------------------------
  Control          1.698 ± 0.058                                    0.7144 ± 0.0980                                    149.8 ± 11.42                                    11.60 ± 5.400
  DM + saline      1.211 ± 0.121[^\*^](#TN4){ref-type="table-fn"}   0.3599 ± 0.0521[^\*^](#TN4){ref-type="table-fn"}   55.22 ± 10.99[^\*^](#TN4){ref-type="table-fn"}   3.300 ± 1.500[^\*^](#TN4){ref-type="table-fn"}
  DM + Metformin   1.662 ± 0.049[^\#^](#TN5){ref-type="table-fn"}   0.5774 ± 0.0994[^\#^](#TN5){ref-type="table-fn"}   139.4 ± 66.20[^\#^](#TN5){ref-type="table-fn"}   14.25 ± 13.15[^\#^](#TN5){ref-type="table-fn"}
  DM + LBP         1.664 ± 0.062[^\#^](#TN5){ref-type="table-fn"}   0.5334 ± 0.0396[^\#^](#TN5){ref-type="table-fn"}   137.0 ± 31.30[^\#^](#TN5){ref-type="table-fn"}   12.17 ± 3.440[^\#^](#TN5){ref-type="table-fn"}

P \< 0.05 vs. Control;

P \< 0.05 vs. DM + saline group.

Effects of Metformin and LBP Treatment on the Number of Spermatogonia and Spermatocytes in Diabetic Rats
--------------------------------------------------------------------------------------------------------

In the saline-treated diabetic rats, the seminiferous tubules were atrophic, with only 1--3 layers of cells in a disordered arrangement with many vacuoles; the spermatogenic cells were sparsely arranged, and the sperm number was largely reduced ([Figure 1A](#F1){ref-type="fig"}). Metformin and LBP treatments both attenuated the pathological changes in the seminiferous tubules of diabetic rats ([Figure 1A](#F1){ref-type="fig"}). Quantification of the spermatogonia and spermatocytes showed that the saline-treated diabetic rats had a reduced number of spermatogonia and spermatocytes compared to the controls ([Figures 1B,C](#F1){ref-type="fig"}), while metformin and LBP treatments both increased the number of spermatogonia and spermatocytes in the testicular tissues compared to saline-treated diabetic rats ([Figures 1B,C](#F1){ref-type="fig"}).

![Effects of metformin and LBP treatment on the number of spermatogonia and spermatocytes in diabetic rats. **(A)** Hematoxylin and eosin staining of testicular tissue from control rats and diabetic rats treated with saline, metformin, or LBP. **(B)** Quantification of spermatogonia in testicular tissues from different treatment groups. **(C)** Quantification of spermatocytes in testicular tissues from different treatment groups. *N* = 6. Significant differences between treatment groups are indicated as \**P* \< 0.05.](fendo-11-00164-g0001){#F1}

Effects of Metformin and LBP Treatment on PCNA Expression in Testis From Diabetic Rats
--------------------------------------------------------------------------------------

PCNA mRNA expression levels in the testicular tissues from different treatment groups were evaluated by qRT-PCR. We observed that the mRNA expression was significantly suppressed in the saline-treated diabetic rats compared to the control group and that metformin and LBP treatments both increased PCNA mRNA expression in diabetic rats ([Figure 2A](#F2){ref-type="fig"}). Immunohistochemically determined PCNA protein expression in the testicular tissues from different treatment groups and from diabetic rats treated with saline showed a decrease in the number of PCNA-positive cells in the testicular tissues compared to the control group ([Figures 2B,C](#F2){ref-type="fig"}). Consistently, metformin and LBP treatments both increased the number of PCNA-positive cells in the testicular tissues of diabetic rats compared with saline treatment ([Figures 2B,C](#F2){ref-type="fig"}).

![Effects of metformin and LBP treatment on PCNA expression in testicular tissues of diabetic rats. **(A)** qRT-PCR analysis of PCNA mRNA expression in testis from control rats and diabetic rats treated with saline, metformin, or LBP. **(B)** Immunohistochemistry analysis of PCNA expression in testis from control rats and diabetic rats treated with saline, metformin, or LBP. Slices in the upper row show PCNA-positive cells; slices in the lower row are negative controls. **(C)** Quantification of PCNA-positive cells in testis from different treatment groups. *N* = 6. Significant differences between treatment groups are indicated as \**P* \< 0.05 and \*\**P* \< 0.01.](fendo-11-00164-g0002){#F2}

Effects of Metformin and LBP Treatment on Apoptosis in Testicular Tissues From Diabetic Rats
--------------------------------------------------------------------------------------------

The qRT-PCR results showed that Bcl-2 mRNA was downregulated and the mRNA expressions of Bax and caspase-3 were upregulated in the saline-treated diabetic rats when compared to the control group. Metformin and LBP treatments attenuated the DM-induced changes in the apoptosis-related mediators ([Figures 3A--C](#F3){ref-type="fig"}). Using TUNEL assay, we identified an increase in the number of apoptotic cells in the testicular tissues from different treatment groups and from diabetic rats with saline treatment compared to the control group ([Figures 3D,E](#F3){ref-type="fig"}). Consistently, metformin and LBP treatments both decreased the number of apoptotic cells in the testicular tissues of diabetic rats compared with saline treatment ([Figures 3D,E](#F3){ref-type="fig"}).

![Effects of metformin and LBP treatment on the cell apoptosis in testis from diabetic rats. **(A--C)** qRT-PCR analysis of Bcl-2, Bax, and caspase-3 expression in testis from control rats and diabetic rats treated with saline, metformin, or LBP. **(D)** TUNEL assay analyzed the apoptotic cells in testis from control rats and diabetic rats treated with saline, metformin, or LBP. Slices in the upper row show apoptotic cells; slices in the lower row are negative controls **(E)** Quantification of apoptotic cells in testis from different treatment groups. *N* = 6. Significant differences between treatment groups are indicated as \**P* \< 0.05.](fendo-11-00164-g0003){#F3}

Effects of Metformin and LBP Treatment on SIRT1 Expression in Testicular Tissues From Diabetic Rats
---------------------------------------------------------------------------------------------------

SIRT1 mRNA expression was significantly suppressed in the saline-treated diabetic rats compared to the control group, and metformin and LBP treatments both increased SIRT1 mRNA expression in diabetic rats ([Figure 4A](#F4){ref-type="fig"}). Immunohistochemical analysis of SIRT1 in the testes from different treatment groups and from diabetic rats treated with saline showed a decrease in the number of SIRT1-positive cells in the testicular tissues compared to the control group ([Figures 4B,C](#F4){ref-type="fig"}). Consistently, metformin and LBP treatments both increased the number of SIRT1-positive cells in the testicular tissues of diabetic rats when compared to treatment with saline ([Figures 4B,C](#F4){ref-type="fig"}).

![Effects of metformin and LBP treatment on SIRT1 expression in testis from diabetic rats. **(A)** qRT-PCR analysis of PCNA mRNA expression in the testis from control rats and diabetic rats treated with saline, metformin, or LBP. **(B)** Immunohistochemistry analysis of SIRT1 expression in the testis from control rats, and diabetic rats treated with saline, metformin, or LBP. Slices in the upper row show SIRT1-positive cells; slices in the lower row are negative controls **(C)** Quantification of SIRT1-positive cells in testis from different treatment groups. *N* = 6. Significant differences between treatment groups are indicated as \*\**P* \< 0.01.](fendo-11-00164-g0004){#F4}

Effects of Metformin and LBP Treatment on HIF-1α Expression in Testicular Tissues From Diabetic Rats
----------------------------------------------------------------------------------------------------

The mRNA expression of HIF-1α was downregulated in the testicular tissues of saline-treated diabetic rats compared to the control group ([Figure 5A](#F5){ref-type="fig"}). Metformin and LBP treatments both significantly upregulated HIF-1α mRNA expression in the testicular tissues compared to saline-treated diabetic rats ([Figure 5A](#F5){ref-type="fig"}). Immunohistochemical analysis of HIF-1α protein expression in the testicular tissues from the different treatment groups and diabetic rats with saline showed a decrease in the number of HIF-1α-positive cells in the testicular tissues compared to the control group ([Figures 5B,C](#F5){ref-type="fig"}). Consistently, metformin and LBP treatments both increased the number of HIF-1α-positive cells in the testicular tissues of diabetic rats compared with the control group ([Figures 5B,C](#F5){ref-type="fig"}).

![Effects of metformin and LBP treatment on HIF-1α expression in testis from diabetic rats. **(A)** qRT-PCR analysis of HIF-1α mRNA expression in testis from control rats and diabetic rats treated with saline, metformin, or LBP. **(B)** Immunohistochemistry analysis of HIF-1α expression in testis from control rats and diabetic rats treated with saline, metformin, or LBP. Slices in the upper row show HIF-1 α -positive cells; slices in the lower row are negative controls. **(C)** Quantification of HIF-1α-positive cells in testis from different treatment groups. *N* = 6. Significant differences between treatment groups are indicated as \**P* \< 0.05 and \*\**P* \< 0.01.](fendo-11-00164-g0005){#F5}

Discussion {#s4}
==========

LBP is a water-soluble polysaccharide extracted from *Lycium barbarum* and exerts multiple biological functions including protective effects on the male reproductive system ([@B30]). In this study, our results showed that STZ-induced diabetic rats showed impaired spermatogenic function with a decrease in PCNA, SIRT1, and HIF-1α expression and an increase in cell apoptosis in the testes. Both metformin and LBP treatments increased the expression of PCNA and inhibited cell apoptosis in the testes of diabetic rats. In addition, the expressions of SIRT1 and HIF-1α in diabetic testes were also upregulated by metformin and LBP treatments.

The molecular mechanisms of LBP-mediated protective effects on the male reproductive system have been elucidated in several studies. It has been found that LBPs could reduce irradiation-induced spermatogenic cell apoptosis by upregulating Bcl-2 expression and decreasing Bax expression and mitochondrial potential ([@B31]). In addition, LBP could recover serum testosterone levels, increase superoxide dismutase activity, decrease malondialdehyde levels, promote oxidative balance, and rescue testicular DNA damage in irradiated rats ([@B13]). LBP could also improve sperm density and motility, increase the rate of normal sperm morphology, enhance superoxide dismutase activity, and decrease the nitrate nitrogen level in testes of mice treated with cyclophosphamide ([@B15]). In STZ-induced diabetic male mice, LBP could enhance spermatogenesis by increasing antioxidant activity and inhibiting apoptosis in the testes ([@B19]). Consistently, our data showed the LBP treatment could significantly decrease the level of blood glucose, improve insulin resistance, and increase the weight of testis and epididymis as well as the number and motility of sperm. After LBP treatment, the pathologic changes in the spermatogenic tubules improved significantly, with increased numbers of spermatogenic cells. LBP treatment significantly upregulated PCNA expression at both the mRNA and protein levels in the testes of diabetic rats. Moreover, LBP treatment also reduced cell apoptosis in the testes of diabetic rats by downregulating Bax and caspase-3 expression and upregulating Bcl-2 expression. Collectively, our data indicate that LBP exerts protective effects against DM-induced male reproductive damage by increasing cell proliferation and inhibiting cell apoptosis in the testis.

SIRT1 belongs to the mammalian Sirtuin gene family and functions as an NAD-dependent histone deacetylase. Notably, SIRT1 plays a key role in regulating glucose metabolism ([@B32]). DM-induced germ cell apoptosis was associated with a decrease in SIRT1 expression in male mice ([@B33]), and *Sirt1* knockdown impaired spermatogenesis and germ cell function ([@B34]). Our results showed that DM induced the downregulation of SIRT1 in the testes of diabetic rats and that LBP treatment increased the mRNA and protein expression levels of SIRT1 in the testes of diabetic rats. Our findings are in agreement with previous studies showing that LBP enhanced SIRT1 expression in hypoxic pulmonary vascular smooth muscle cells and in high-fat-diet-induced hepatic steatosis ([@B35], [@B36]). The testis is a relatively hypoxic tissue, and HIF-1α regulates the primary transcriptional responses to hypoxic stress in normal and transformed cells, which plays an adaptive role in conferring protection against cell death in the testes ([@B28]). In addition, SIRT1 stabilizes HIF-1α by direct binding and deacetylation during hypoxia ([@B29]). In the present study, we showed that DM-induced downregulation of HIF-1α expression in the testes, and LBP treatment increased HIF-1α expression levels in the testes of diabetic rats. Collectively, these results imply that LBP exerted protective effects on DM-induced reproductive injury by regulating SIRT1 and HIF-1α expression in the testes. Our study proposes that LBP could increase the expression of SIRT1, which results in the stabilization of HIF-1α in the testis under diabetic conditions, and that the upregulated HIF-1α expression may confer testicular production in diabetic rats.

Metformin has been widely used in the treatment of type 2 diabetes; however, metformin treatment is often associated with side effects including nausea, vomiting, diarrhea, and other gastrointestinal reactions, which limits its use for treating diabetic complications ([@B37], [@B38]). Our results showed that the protective effect on diabetic testicular injury is comparable to that of metformin. Because of the rarity of side effects of LBP, it may represent a better strategy for managing male reproductive dysfunction in DM. In this study, we used STZ in combination with a high-fat diet to induce diabetes in the animals; thus, the model used in this study can be considered as a mixed model of type 1/type 2 diabetes. In future studies, we would use proper mouse strains to induce type 2 diabetes and to further examine the protective effects of LBP on the male reproductive system under type 2 diabetic conditions. The findings of this study are still in the preliminary stages, and the underlying molecular mechanisms are still unclear and require further investigation.

In conclusion, our results indicated the protective effects of LBP on the DM-induced male reproductive damage in rats, and mechanistic studies showed that LBP exerted these protective effects by increasing cell proliferation, inhibiting cell apoptosis, and regulating SIRT1/HIF-1α expression in the testes of diabetic rats.
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